| Literature DB >> 29870668 |
Wei Hu1, Xu-Sheng Huang2, Ji-Feng Wu3, Liang Yang4, Yong-Tang Zheng2, Yue-Mao Shen4, Zhi-Yu Li5, Xun Li4.
Abstract
DNA topoisomerase II (topo II) is an important enzyme involved in DNA replication, recombination, and repair. Despite the popular applications of topo II inhibitors in cancer therapy, there is still an urgent need to upgrade topo II inhibitors to cope with drug resistance and severe adverse effects. Accordingly, novel topo II catalytic or multitarget topo II inhibitors are gaining more attention and make it possible to ease the toxic limitations of topo II poisons. In this review, medicinal chemistry approaches are mainly discussed toward the development of potent topo II inhibitors with low toxicities.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29870668 DOI: 10.1021/acs.jmedchem.7b01202
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446